Endothelin-1, interleukin-6, and interleukin-8 levels increase in patients with burns

Journal of Burn Care and Rehabilitation

Volumn 17, Issue 5, 1996, Pages 384-389

  McMillen, Marvin A ^a   Huribal, Marsel ^b   Cunningham, Michael E ^b   Bala, R J ^b   Pleban, Walter E ^b   D'Aiuto, Michael L ^b  

^a MICHAEL REESE HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BURN; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; LEUKOCYTE ACTIVATION; MONOCYTE; PATHOGENESIS; REFERENCE VALUE;

EID: 0029758895     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199609000-00003     Document Type: Article

References (64)

1. Wolfe JHN, Wu AVO, O'Connor NE, et al. Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch Surg 1982;117:1266-71.
2. Zapata-Sirvent RL, Hansbrough JF. Postburn immunosuppression in an animal model; III: maintenance of normal splenic helper and suppressor lymphocyte subpopulations by immunomodulating drugs. Surgery 1985;97:721-7.
3. Wood JJ, Grbic JT, Rodrick ML, et al. Suppression of interleukin-2 production in an animal model of thermal injury is related to prostaglandin synthesis. Arch Surg 1987;122:179-84.
4. Miller-Graziano CL, Szabo G, Kodys K, Griffey K. Aberrations in post-trauma monocyte subpopulation: role in septic shock syndrome. J Trauma 1990;30(suppl):S86-96.
5. Bjornson AB, Somers SD, Knippenberg RW, Bjornson HS. Circulating factors contribute to elevation of intracellular cyclic-3′, 5′-adenosine monophosphate and depression of superoxide anion production in polymorphonuclear leukocytes following thermal injury. J Leukoc Biol 1992;52:407-14.
6. Dong Y, Abdullah K, Yan Z, et al. Effect of thermal injury and sepsis on neutrophil function. J Trauma 1993;34:417-21.
7. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-15.
8. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family, three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 1989;86:2863-7.
9. McMillen MA, Sumpio BE. Endothelins: polyfunctional cytokines. J Am Coll Surg 1995;180:621-37.
10. McMillen MA, Huribal M, Cunningham ME, et al. Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6. Crit Care Med 1995;23: 34-40.
11. ++ mobilization through its specific receptors in murine peritoneal macrophages. FEBS Lett 1991;280: 103-6.
12. Huribal M, McMillen MA, Kumar R, et al. Endothelin-stimulated monocyte supernatants enhance neutrophil superoxide production. Shock 1994;1:184-7.
13. 4. J Surg Res 1993;54:331-5.
14. Huribal M, Cunningham ME, Kumar R, Pleban WE, D'Aiuto ML, McMillen MA. Endothelin-1 levels in patients with burns covering more than 20% body surface area. J Burn Care Rehabil 1995;16:23-6.
15. 2 levels increase in patients with burns. J Am Coll Surg 1995;180:318-22.
16. Filep JG, Battistini B, Sirois P. Endothelin induces thromboxane release and contraction of isolated guinea pig airways. Life Sci 1990;47:1845-50.
17. Badr KF, Murray JJ, Breyere MD, et al. Mesangial cell, glomerular, and renal vascular response to endothelin in rat kidney. J Clin Invest 1989;83:336-42.
18. Kitajima T, Yamaguchi T, Iani K, et al. Role of endothelin and platelet activating factor in indomethacin-induced gastric mucosal injury in rats. Digestion 1993;54:156-9.
19. Gandhi CR, Stephenson K, Olson MS. Endothelin, a potent peptide agonist in the liver. J Biol Chem 1990;265:17432-5.
20. Isales CM, Nathanson MH, Bruck R. Endothelin-1 induces cholestasis which is mediated by an increase in portal pressure. Biochem Biophys Res Commun 1993;191:1244-51.
21. Miyauchi T, Yanagisawa M, Tomizawa T, et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989;2:53-4.
22. Pittet JP, Morel DR, Hemsen A, et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991;213:261-8.
23. Voerman HJ, Stehouwer CD, Van Kamp GJ, et al. Plasma endothelin levels are increased during septic shock. Crit Care Med 1992;20:1097-1101.
24. Cunningham ME, Huribal M, Bala RJ, McMillen MA. Endothelin-1 and 4 stimulate monocyte production of cytokines. Crit Care Med. In press. Submitted.
25. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
26. Baggiolini M, Walz A, Kunkel SL. NAP-1/Interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84:1045-51.
27. Moldawer LL. Biology of proinflammatory cytokines and their antagonists. Crit Care Med 1994;22:S3-8.
28. Fong Y, Moldawer LL, Shires GT, Lowry SF. The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 1990;170:363-78.
29. Akira S, Hirano T, Taga T, et al. Biology of multifunctional cytokines, IL-6 and related molecules (IL-1 and TNF). FASEB J 1990;4:2860-7.
30. Baigne RJ, Lamont PM, Dallman M, Morris PJ. The release of interleukin-1β precedes that of interleukin-6 in patients undergoing major surgery. Lymphokine Cytokine Res 1991; 10:253-6.
31. Rodriguez JL, Miller CG, Garner WL, Till GO, Guerrero P, Moore NP, et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993;34:684-94.
32. Battafarano RJ, Dunn DL. Contribution of local cytokine production to the systemic host septic response. Crit Care Med 1994;22:7-8.
33. Fisher CJ, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 1994;22:12-21.
34. Froon AHM, Bemelmans MHA, Greve JW, van der Linden C, Buurman WA. Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis, syndrome: correlation with plasma creatinine values. Crit Care Med 1994;22: 803-9.
35. Drost AC, Burleson DG, Cioffi WG, et al. Plasma cytokines after thermal injury and their relationship to infection. Ann Surg 1993;218:74-8.
36. Guo Y, Dickerson C, Chrest FJ, Adler WH, Munster AM, Winchurch RA. Increased levels of circulating interleukin-6 in burn patients. Clin Immunol Immunopathol 1990;54:361-71.
37. Drost AC, Burleson DG, Cioffi WG, Jordan BS, Mason AD, Pruitt BA. Plasma cytokines following thermal injury and their relationship with patients' mortality, burn size and time postburn. J Trauma 1993;35:335-9.
38. Nijsten MW, Hack CE, Helle M, ten Duis HJ, Klasen HJ, Aarden LA. Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 1991;109:761-7.
39. Ertel W, Faist E, Nestle C, Hueltner L, Storck M, Schildbery FW. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res 1990;48:622-8.
40. Shimada M, Winchurch RA, Beloucif S, Robotham JL. Effect of anesthesia and surgery on plasma cytokine levels. J Crit Care 1993;8:109-16.
41. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991;88:1747-54.
42. Moskowvitz H, Shofer F, Mignott H, Behrman A, Kilpatrick L. Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 1994;22:1102-7.
43. Donnelly TJ, Meade P, Jegels M, Cryer HG, Law MM, Hugli TE, et al. Cytokine complement and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 1994;22:768-76.
44. Lin RY, Astiz ME, Saxon JC, Saha DC, Rackow EC. Relationship between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med 1994;22:1595-1603.
45. Ohzato H, Monden M, Yoshizaki K, Ogata A, Nishimoto N, Gotoh M, et al. Systemic production of interleukin-6 following acute inflammation. Biochem Biophys Res Commun 1993;197:1556-62.
46. Ueyama M, Maruyama I, Osame M, Sawada Y. Marked increase in plasma interleukin-6 in burn patients. J Lab Clin Med 1992;120:693-8.
47. Schluter B, Konig B, Bergmann U, Muller FE, Konig W. Interleukin-6 a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma 1991;31: 1663-70.
48. Zhou D, Munster AM, Winchurch RA. Inhibitory effect of interleukin-6 on immunity. Arch Surg 1992;127:65-9.
49. 4 and neutrophil attractant/activation protein (interleukin-8) sequentially in response to stimulation with lipopolysaccharide and zymosan. J Clin Invest 1990;86:1556-64.
50. Friedlan JS, Suputtamongkol Y, Remick DG, Chaowagul W, Strieter RM, Kunkel SL, et al. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992;60:2402-8.
51. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-9.
52. Feuerstein G, Rabinovici R. Importance of interleukin-8 and chemokines in organ injury and shock. Crit Care Med 1994; 22:550-1.
53. Gemsa D, Steggemann L, Menzel J, Till G. Release of cyclic AMP from macrophages by stimulation with prostaglandins. J Immunol 1975;114:1422-4.
54. 2 on the gamma-interferon induction of antigen-presenting ability in P388D1 cells and on IL-2 production by T-cell hybridomas. Cell Immunol 1985;90:154-66.
55. 2 dependent suppression of interleukin-2 production in patients with major injury. J Trauma 1987;27:837-95.
56. 2 production in severely injured patients. Arch Surg 1988;123:293-9.
57. Ninnemann JL, Stockland AE. Participation of prostaglandin E in immunosuppression following thermal injury. J Trauma 1984;24:201-7.
58. Wood JJ, Grbic JT, Rodrick ML, et al. Suppression of interleukin 2 production in an animal model of thermal injury is related to prostaglandin synthesis. Arch Surg 1987;122:179-84.
59. Antonacci AC, Calvano SE, Reaves LE, et al. Autologous and allogeneic mixed-lymphocyte responses following thermal injury in man: the immunomodulatory effects of interleukin 1, intefleukin 2, and a prostaglandin inhibitor, WY-18251. Clin Immunol Immunopathol 1984;30:304-20.
60. Deitch EA, Winterton J, Berg R. Thermal injury promotes bacterial translocation from the gastrointestinal tract in mice with impaired T-cell mediated immunity. Arch Surg 1986; 121:97-101.
61. Alexander JW, Gianotti L, Pyles T, et al. Distribution and survival of E. coli translocating from the intestine after thermal injury. Ann Surg 1991;213:558-66.
62. Munster AM, Smith-Meek M, Dickerson C, Winchurch RA. Translocation: incidental phenomenon or true pathology? Ann Surg 1993;3:321-7.
63. Lefer AM, Tsao PS, Lefer DJ, Ma XL. Role of endothelial dysfunction after myocardial ischemia. FASEB J 1991;5: 2029-34.
64. McMillen MA, Huribal M, Sumpio BE. A common pathway of endothelial-leukocyte interactions in shock, ischemia and reperfusion. Am J Surg 1993;166:563-7.